In turn, the interaction of LOXL2 with myristoylated alanine-rich C kinase substrate-like 1 (MARCKSL1) improves the survival of cancer cells by inhibiting the MARCKSL1-induced apoptosis [129]. The gene discussed is LOXL2; the disease is cancer.